The University of Luxembourg is a multilingual, international research university. There is a vacancy in the Cancer Cell Biology and Drug Discovery Group of Prof.
Dr. Daniel Abankwa at the Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine :
Doctoral candidate (PhD student) in the field of RAS cancer drug development (M / F)
The PhD student will work in the Cancer Cell Biology and Drug Discovery group under the supervision of Prof. Dr. Daniel Abankwa.
The group focuses on understanding how the notorious oncogene RAS drives cancer cell stemness and on drug targeting RAS (eRASeCancer.wordpress.com).
The particular aim of this project is to develop a protein-protein interaction inhibiting peptidomimetic against a novel target interface in the RAS pathway.
Moreover, we will be looking for competitive or allosteric small molecule inhibitors with a similar activity. The project will be carried out in tight collaboration with Prof.
Tom Grossmann (Vrije Universiteit Amsterdam), an expert in peptidomimetics.
We will employ a broad spectrum of techniques, including biochemistry
Candidates should submit the following documents :
2) rating of your aptitude and skills in (bio)chemistry and molecular biology. The University of Luxembourg is an equal opportunity employer.
Please send your application as one merged PDF, AND via the online submission link by 15 / 05 / 2020. For further information, please contact Prof.
Daniel Abankwa (daniel.abankwa uni.lu).